Features
The Features section includes articles on topics, events, people, and initiatives of interest to the oncology community.
Jan 20, 2022
Dr. Parry is working to identify the basic genetic changes and molecular pathways that cause transformation to improve our understanding of Richter’s syndrome.
Jan 20, 2022
Conquer Cancer, the ASCO Foundation, called on oncology leaders to support bold but practical initiatives to help achieve greater equity in cancer care, and a host of generous donors have answered.
Jan 14, 2022
The 2021 ASCO Quality Care Symposium (QCS) was ASCO’s first hybrid in-person and online meeting; it brought together oncology professionals from around the globe to discuss innovative strategies to improve the quality of care for millions of people living with cancer worldwide.
Jan 14, 2022
The hosts of the “Oncology, Etc.” podcast series share their love of the art of conversation and its healing properties.
Jan 11, 2022
Dr. Beverly Moy recognizes that creating a robust community of successful female scientists will inspire younger women to pursue careers in scientific research.
Jan 04, 2022
ASCO’s work aims to address all of the important differences that can impact access to cancer care and outcomes, including age, gender, sexual orientation, and geography—both in the United States and internationally.
Dec 17, 2021
Seven new members were also elected to the ASCO Board of Directors and Nominating Committee.
Oct 27, 2021
While there has been progress made in treatments for breast cancers overall, advances specific to invasive lobular carcinoma (ILC) have not kept pace. The Lobular Breast Cancer Alliance (LBCA) is working to change the conversation.
Oct 15, 2021
The internship program aims to increase diversity in the oncology workforce by introducing medical students from populations underrepresented in medicine to oncology concepts and careers.
Sep 01, 2021
Nearly 20 years since receiving a Conquer Cancer Young Investigator Award and Career Development Award, Dr. Yael P. Mossé is launching a new study to unmask how the MYCN culprit causes certain diseases to develop resistance to existing cancer drugs.